OpenAI’s Sam Altman downplays impact of DeepSeek: ‘Wildly overstated’
OpenAI CEO Sam Altman downplayed the significance of a new artificial intelligence (AI) model released by Chinese startup ...
Column: OpenAI accuses China of stealing its content, the same accusation that authors have made against OpenAI
Authors and artists have accused OpenAI of stealing their content to 'train' its bots--but now OpenAI is accusing a Chinese ...
Oh Dear, Did Someone Steal Something From OpenAI?
OpenAI is investigating whether DeepSeek used its work to build its model—an ironic twist for a company that’s built plenty ...
FT1d
CEO, appointment and succession: Board’s most critical responsibility
In a rapidly changing business and societal landscape where artificial intelligence (AI), digitisation, diversity, equity and ...
OpenAI ex–board member Helen Toner says revoking ban on Nvidia AI chip exports would be a ‘huge victory’ for China
Revoking export controls on Nvidia AI chips, or GPUs, would be a “huge victory” for China and DeepSeek, who see access to the sophisticated chips as a strategic necessity for AI dominance, said Helen ...
Shadows of Musk in the Government’s Buyouts Plan
President Trump’s chief cost-cutter cheered an effort to persuade federal workers to quit — in a fashion that closely ...
DEI Under Fire: Trump Eliminates Military Diversity Programs—Here’s A List Of Major Organizations Dropping DEI
Following Trump's lead, organizations including Walmart, Lowe’s and Meta, have announced they would scale back their ...
TASS2d
Yandex won’t rename Gulf of Mexico on its maps
However, according to the statement, Yandex Maps tries to keep track of synonyms for its search data base, so it will be possible to find the place by either of the two names ...
Trump and Musk are at odds again. This time over the UK prime minister.
In an interview with the BBC, Trump said Keir Starmer, the leader of the UK's ruling Labour Party, was doing a "very good job." ...
ATAI Life Sciences supervisory board member resigns
ATAI Life Sciences N.V. (NASDAQ:ATAI), a pharmaceutical company specializing in the development of treatments for mental health conditions with a market capitalization of $263 million, announced the ...